Bangladeshi trial claims 100% cure for Covid-19 with combo drugs

Official End to Covid 19 Health Emergency Adds to priorities of children

A trial of two available drugs by a team of Bangladeshi doctors has claimed have produced 100 percent cure for the Covid-19 patients, raising hopes of a complete cure for those affected by the deadly virus.

The team including prominent physicians claimed that the trial of the combo cured the patients with acute symptoms of the coronavirus. They used frequently used antiprotozoal medicine called Ivermectin in a single dose with Doxycycline, an antibiotic.

“We have got astounding results. Out of 60 Covid-19 patients, all recovered as the combination of the two drugs were applied,” said Professor Dr Md Tarek Alam, the head of medicine department at private Bangladesh Medical College Hospital (BMCH).

“My team was prescribing the two medicines only for coronavirus patients, most of them initially reporting with respiratory problems with related complaints, later to be tested Covid-19 positive,” he said.

Claiming that the efficacy of the drug developed by them was such that patients recovered from the virus within 4 days, he said, adding that there were no side effects of it.

“We first ask them to be tested for Covid-19 and when found coronavirus positive we apply the drugs . . . they are recovering within four days”.

“The repeated or second tests, in line with the procedure, reconfirmed them Covid-19 negative in all the cases under the research which found the combination to have no side effects on patients either,” he said.

“We are hundred per cent hopeful” about the effectiveness of the combination, he said, adding they by now contacted the concerned government regulators and preparing to exhaust international procedures for acknowledgement of the drugs for the Covid-19 treatment.

Alam said his team was preparing a paper on the development of the drug for an international journal, as required for scientific review and acknowledgement.


Please enter your comment!
Please enter your name here